quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:44:57·70d
INSIDERFiling
Lyell Immunopharma Inc. logo

Chief Scientific Officer Lee Gary K. sold $39,085 worth of shares (1,671 units at $23.39), decreasing direct ownership by 9% to 16,938 units (SEC Form 4)

LYEL· Lyell Immunopharma Inc.
Health Care
Original source

Companies

  • LYEL
    Lyell Immunopharma Inc.
    Health Care

Recent analyst ratings

  • Apr 10UpdateNeedham$44.00
  • Mar 9UpdateCitizens$34.00
  • Dec 9UpdateH.C. Wainwright$45.00
  • Oct 30UpdateBofA Securities$1.00
  • Jun 27UpdateH.C. Wainwright$1.00
  • Aug 28UpdateJP Morgan$5.00

Related

  • SEC9d
    SEC Form EFFECT filed by Lyell Immunopharma Inc.
  • ANALYST13d
    Needham initiated coverage on Lyell Immunopharma with a new price target
  • PR16d
    Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
  • SEC20d
    SEC Form S-3 filed by Lyell Immunopharma Inc.
  • INSIDER38d
    SEC Form 4 filed by Chief Fin. and Bus. Officer Shah Smital
  • INSIDER38d
    SEC Form 3 filed by new insider Shah Smital
  • SEC42d
    SEC Form S-8 filed by Lyell Immunopharma Inc.
  • SEC42d
    SEC Form 10-K filed by Lyell Immunopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022